Human gene
MYBPC3 myosin binding protein C3
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2951 | Cardiomyopathy, hypertrophic, MYBPC3-related, autosomal dominant | domestic cat | MYBPC3 | one to one | Target evidence |
58.5
|
| 2952 | Cardiomyopathy, hypertrophic, MYBPC3-related, autosomal recessive | domestic cat | MYBPC3 | one to one | Target evidence |
58.5
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| hypertrophic cardiomyopathy 4 | MONDO:0007268 | 0.84 | 868 |
| left ventricular noncompaction 10 | MONDO:0014163 | 0.79 | 408 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.